Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies

C Papageorgiou, G Jourdi, E Adjambri… - Clinical and applied …, 2018 - journals.sagepub.com
Disseminated intravascular coagulation (DIC) is an acquired clinicobiological syndrome
characterized by widespread activation of coagulation leading to fibrin deposition in the …

Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding

KN Iskander, MF Osuchowski… - Physiological …, 2013 - journals.physiology.org
Sepsis represents the host's systemic inflammatory response to a severe infection. It causes
substantial human morbidity resulting in hundreds of thousands of deaths each year …

Pathophysiology of coagulation and emerging roles for extracellular vesicles in coagulation cascades and disorders

H Al-Koussa, I AlZaim, ME El-Sabban - Journal of clinical medicine, 2022 - mdpi.com
The notion of blood coagulation dates back to the ancient Greek civilization. However, the
emergence of innovative scientific discoveries that started in the seventeenth century …

Fibrinolysis: the key to new pathogenetic mechanisms

E Zorio, J Gilabert-Estelles, F Espana… - Current medicinal …, 2008 - ingentaconnect.com
The fibrinolytic system includes a broad spectrum of proteolytic enzymes with physiological
and pathophysiological functions in several processes, such as haemostatic balance, tissue …

[HTML][HTML] Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

BN Bouma, JCM Meijers - Journal of Thrombosis and Haemostasis, 2003 - Elsevier
Recently, a new inhibitor of fibrinolysis was described, which downregulated fibrinolysis
after it was activated by thrombin, and was therefore named TAFI (thrombin-activatable …

Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis

M Colucci, BM Binetti, MG Branca, C Clerici, A Morelli… - Hepatology, 2003 - Elsevier
Hyperfibrinolysis is thought to contribute to bleeding associated with advanced cirrhosis.
Thrombin activatable fibrinolysis inhibitor (TAFI) is a plasma precursor of a …

Coagulation in sepsis

A Amaral, SM Opal, JL Vincent - Intensive care medicine, 2004 - Springer
Coagulation abnormalities, ranging from a simple fall in platelet count to full-blown
disseminated intravascular coagulation, are a common occurrence in critically ill patients …

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

BN Bouma, PF Marx, LO Mosnier, JCM Meijers - Thrombosis research, 2001 - Elsevier
Recently, a new inhibitor of fibrinolysis was described. This inhibitor downregulated
fibrinolysis after it was activated by thrombin, and was therefore named TAFI (thrombin …

Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis

LO Mosnier, BN Bouma - Arteriosclerosis, thrombosis, and …, 2006 - Am Heart Assoc
The coagulation and fibrinolytic systems safeguard the patency of the vasculature and
surrounding tissue. Cross regulation of coagulation and fibrinolysis plays an important role …

Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys?—A scoping review

A Nowroozpoor, D Gutterman, B Safdar - Microvascular Research, 2021 - Elsevier
Although microvascular dysfunction (MVD) has been well characterized in individual organs
as different disease entities, clinical evidence is mounting in support of an underlying …